Predictions
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.83
06.03.23
06.03.23
€15.01
06.03.24
06.03.24
-52.04%
07.03.24
07.03.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€136.50
06.03.23
06.03.23
€191.43
06.03.24
06.03.24
-20.88%
07.03.24
07.03.24
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.83
06.03.23
06.03.23
€20.64
06.03.24
06.03.24
-52.04%
07.03.24
07.03.24
Monster Beverage Corp.
Start price
Target price
Perf. (%)
€48.20
06.03.23
06.03.23
€56.30
06.03.24
06.03.24
10.33%
07.03.24
07.03.24
Monster Beverage Corp.
Start price
Target price
Perf. (%)
€48.20
06.03.23
06.03.23
€56.30
06.03.24
06.03.24
10.33%
07.03.24
07.03.24
Monster Beverage Corp.
Start price
Target price
Perf. (%)
€48.20
06.03.23
06.03.23
€56.30
06.03.24
06.03.24
10.33%
07.03.24
07.03.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.29
06.03.23
06.03.23
-
06.03.24
06.03.24
-13.18%
17.03.23
17.03.23
Risky Investment
Deutsche Lufthansa AG
Start price
Target price
Perf. (%)
€10.87
06.03.23
06.03.23
€14.00
06.03.24
06.03.24
-28.08%
15.11.23
15.11.23
Could be worthwhile Investment >10% per year
Fair valuation
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.44
06.03.23
06.03.23
-
06.03.24
06.03.24
-57.46%
17.03.23
17.03.23
Could be worthwhile Investment >10% per year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€1.47
06.03.23
06.03.23
-
06.03.24
06.03.24
-95.09%
07.03.24
07.03.24
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
Deutsche Bank AG
Start price
Target price
Perf. (%)
€11.72
05.03.23
05.03.23
€13.00
05.03.24
05.03.24
1.33%
11.12.23
11.12.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Deutsche Bank AG
Start price
Target price
Perf. (%)
€11.72
05.03.23
05.03.23
€13.00
05.03.24
05.03.24
1.33%
11.12.23
11.12.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Novavax Inc.
Start price
Target price
Perf. (%)
€7.14
05.03.23
05.03.23
-
05.03.24
05.03.24
-22.15%
18.03.23
18.03.23
Probably not worthwhile Investment
Very low/no dividend yield expected